Passage BIO, Inc. (PASG) › Shareholders' EquityPassage BIO, Inc. (PASG) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$12.17M2019: -$56.25M2020: $304.71M2021: $318.66M2022: $201.37M2023: $111.28M2024: $61.26M2025: $18.75M$18.75M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$18.75M-69.4%2024$61.26M-45.0%2023$111.28M-44.7%2022$201.37M-36.8%2021$318.66M+4.6%2020$304.71M+641.7%2019-$56.25M-362.1%2018-$12.17M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share